Logo image of IH

IHUMAN INC (IH) Stock Fundamental Analysis

NYSE:IH - US45175B1098 - ADR

3 USD
+0.1 (+3.45%)
Last: 9/10/2025, 10:00:49 AM
Fundamental Rating

6

Overall IH gets a fundamental rating of 6 out of 10. We evaluated IH against 79 industry peers in the Entertainment industry. IH has an excellent financial health rating, but there are some minor concerns on its profitability. IH is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

IH had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: IH reported negative net income in multiple years.
In the past 5 years IH always reported a positive cash flow from operatings.
IH Yearly Net Income VS EBIT VS OCF VS FCFIH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

IH has a better Return On Assets (7.51%) than 87.34% of its industry peers.
The Return On Equity of IH (10.95%) is better than 79.75% of its industry peers.
IH has a Return On Invested Capital of 7.22%. This is in the better half of the industry: IH outperforms 78.48% of its industry peers.
IH had an Average Return On Invested Capital over the past 3 years of 11.46%. This is significantly below the industry average of 20.67%.
The last Return On Invested Capital (7.22%) for IH is well below the 3 year average (11.46%), which needs to be investigated, but indicates that IH had better years and this may not be a problem.
Industry RankSector Rank
ROA 7.51%
ROE 10.95%
ROIC 7.22%
ROA(3y)9.23%
ROA(5y)3.94%
ROE(3y)14.49%
ROE(5y)5.97%
ROIC(3y)11.46%
ROIC(5y)N/A
IH Yearly ROA, ROE, ROICIH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K 2K

1.3 Margins

IH's Profit Margin of 11.48% is amongst the best of the industry. IH outperforms 87.34% of its industry peers.
IH has a Operating Margin of 8.58%. This is in the better half of the industry: IH outperforms 69.62% of its industry peers.
IH's Gross Margin of 68.56% is fine compared to the rest of the industry. IH outperforms 79.75% of its industry peers.
In the last couple of years the Gross Margin of IH has grown nicely.
Industry RankSector Rank
OM 8.58%
PM (TTM) 11.48%
GM 68.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.24%
GM growth 5Y2.45%
IH Yearly Profit, Operating, Gross MarginsIH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IH is creating some value.
Compared to 1 year ago, IH has less shares outstanding
IH has more shares outstanding than it did 5 years ago.
There is no outstanding debt for IH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IH Yearly Shares OutstandingIH Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
IH Yearly Total Debt VS Total AssetsIH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 3.09 indicates that IH is not in any danger for bankruptcy at the moment.
The Altman-Z score of IH (3.09) is better than 74.68% of its industry peers.
There is no outstanding debt for IH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.09
ROIC/WACC0.96
WACC7.54%
IH Yearly LT Debt VS Equity VS FCFIH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 3.06 indicates that IH has no problem at all paying its short term obligations.
IH has a Current ratio of 3.06. This is amongst the best in the industry. IH outperforms 88.61% of its industry peers.
IH has a Quick Ratio of 3.02. This indicates that IH is financially healthy and has no problem in meeting its short term obligations.
IH's Quick ratio of 3.02 is amongst the best of the industry. IH outperforms 86.08% of its industry peers.
Industry RankSector Rank
Current Ratio 3.06
Quick Ratio 3.02
IH Yearly Current Assets VS Current LiabilitesIH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

IH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.10%, which is quite impressive.
IH shows a decrease in Revenue. In the last year, the revenue decreased by -9.16%.
The Revenue has been growing by 33.34% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)40.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%512.5%
Revenue 1Y (TTM)-9.16%
Revenue growth 3Y-0.81%
Revenue growth 5Y33.34%
Sales Q2Q%-10.64%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6.28%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IH Yearly Revenue VS EstimatesIH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
IH Yearly EPS VS EstimatesIH Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0 1 -1 2 -2

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.27, the valuation of IH can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of IH indicates a rather cheap valuation: IH is cheaper than 81.01% of the companies listed in the same industry.
IH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.07, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.39 indicates a reasonable valuation of IH.
Based on the Price/Forward Earnings ratio, IH is valued cheaper than 92.41% of the companies in the same industry.
IH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.59.
Industry RankSector Rank
PE 27.27
Fwd PE 10.39
IH Price Earnings VS Forward Price EarningsIH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

IH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. IH is cheaper than 77.22% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.85
IH Per share dataIH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IH does not grow enough to justify the current Price/Earnings ratio.
IH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.34
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.53%, IH is not a good candidate for dividend investing.
IH's Dividend Yield is rather good when compared to the industry average which is at 10.54. IH pays more dividend than 82.28% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.46, IH's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.53%

5.2 History

IH does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
IH Yearly Dividends per shareIH Yearly Dividends per shareYearly Dividends per share 2024 2025 0.02 0.04 0.06 0.08

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
IH Yearly Income VS Free CF VS DividendIH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

IHUMAN INC

NYSE:IH (9/10/2025, 10:00:49 AM)

3

+0.1 (+3.45%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)06-26 2025-06-26
Earnings (Next)09-26 2025-09-26
Inst Owners1.11%
Inst Owner Change-22.74%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap156.66M
Analysts86.67
Price TargetN/A
Short Float %0.07%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield 0.53%
Yearly Dividend0.02
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years1
Ex-Date04-17 2025-04-17 (0.1)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 27.27
Fwd PE 10.39
P/S 1.24
P/FCF N/A
P/OCF N/A
P/B 1.19
P/tB 1.21
EV/EBITDA 11.85
EPS(TTM)0.11
EY3.67%
EPS(NY)0.29
Fwd EY9.63%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.41
BVpS2.53
TBVpS2.49
PEG (NY)4.34
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.51%
ROE 10.95%
ROCE 8.1%
ROIC 7.22%
ROICexc 7.22%
ROICexgc 7.34%
OM 8.58%
PM (TTM) 11.48%
GM 68.56%
FCFM N/A
ROA(3y)9.23%
ROA(5y)3.94%
ROE(3y)14.49%
ROE(5y)5.97%
ROIC(3y)11.46%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)12.85%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.24%
GM growth 5Y2.45%
F-ScoreN/A
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.06
Quick Ratio 3.02
Altman-Z 3.09
F-ScoreN/A
WACC7.54%
ROIC/WACC0.96
Cap/Depr(3y)56.19%
Cap/Depr(5y)248.22%
Cap/Sales(3y)0.71%
Cap/Sales(5y)1.71%
Profit Quality(3y)103.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%512.5%
EPS Next Y6.28%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.16%
Revenue growth 3Y-0.81%
Revenue growth 5Y33.34%
Sales Q2Q%-10.64%
Revenue Next Year8.64%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.81%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-68.85%
FCF growth 3Y105.96%
FCF growth 5Y5.1%
OCF growth 1Y-65.7%
OCF growth 3Y15.59%
OCF growth 5Y6.73%